exhibit 10. 1certain identified information has been excluded from this exhibit because it is both not material and is of the type that vanda treats as private or confidential. such excluded information has been marked with “ [ * * * ]. ” exhibit 10. 1 certain identified information has been excluded from this exhibit because it is both not material and is of the type that vanda treats as private or confidential. such excluded information has been marked with “ [ * * * ]. ” license agreement this license agreement ( this “ agreement ” ) dated as of january 13, 2022 ( the “ effective date ” ) is entered into between vanda pharmaceuticals inc., a delaware corporation with an address at 2200 pennsylvania avenue, n. w., 300e, washington, dc 20037, on behalf of itself and its affiliates ( collectively, “ vanda ” ), msn pharmaceuticals inc., a corporation organized and existing under the laws of delaware, with a place of business at 20 duke road, piscataway, new jersey 08854, and msn laboratories private limited, a corporation organized and existing under the laws of india, with a place of business at msn house, sy no : 10 & 11 whitefields, hitec city, hyderabad, telangana, india 500081, on behalf of themselves and each of their affiliates ( collectively, “ msn ” ), and impax laboratories llc ( f. k. a. impax pharmaceuticals, inc. ), a limited liability company organized and existing under the laws of delaware, with a place of business at 400 crossing boulevard, third floor, bridgewater, nj 08807, on behalf of itself and its affiliates ( collectively “ impax ” ). whereas vanda is the owner of the patent rights ( as the term is defined below ) and has sued msn in the actions captioned vanda pharmaceuticals inc. v. msn pharmaceuticals inc. et al., case nos. 1 : 18 - cv - 690 ( cfc ), 1 : 19 - cv - 926 ( cfc ), 1 : 20 - cv - 235 ( cfc ), 1 : 20 - cv - 318 ( cfc ), 1 : 20 - cv - 1334 ( cfc ), and 1 : 21 - cv - 00283 ( cfc ) ( the “ litigation ” ) which is pending in the united states district court, district of delaware ( the “ court ” )